Melissa Epperly

Insider Reports History

Location
New York, NY
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Melissa Epperly:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Financial Officer Common Stock 451,449 $5,164,577 $11.44 12 Feb 2024 Direct
Roivant Sciences Ltd. Director Common Shares 56,904 $860,957 $15.13 20 Oct 2025 Direct
Zentalis Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 75,000 01 Feb 2024 Direct
Nautilus Biotechnology, Inc. Director Stock Option (Right to Buy) 45,000 23 Jun 2025 Direct
Roivant Sciences Ltd. Director Stock Option (Right to Buy) 33,726 10 Sep 2025 Direct
Kinnate Biopharma Inc. Director Stock Option (right to buy) 0 03 Apr 2024 Direct

Insider Reports Filed by Melissa Epperly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ROIV Roivant Sciences Ltd. 20 Oct 2025 1 $0 4 Director 22 Oct 2025, 21:01
ROIV Roivant Sciences Ltd. 10 Sep 2025 3 -$22,871 4 Director 12 Sep 2025, 21:00
ROIV Roivant Sciences Ltd. 17 Jul 2025 1 $0 4 Director 21 Jul 2025, 21:00
NAUT Nautilus Biotechnology, Inc. 23 Jun 2025 1 $0 4 Director 25 Jun 2025, 16:37
ROIV Roivant Sciences Ltd. 17 Apr 2025 1 $0 4 Director 21 Apr 2025, 21:00
ROIV Roivant Sciences Ltd. 23 Jan 2025 2 -$2,017 4 Director 27 Jan 2025, 21:00
ROIV Roivant Sciences Ltd. 21 Oct 2024 1 $0 4 Director 23 Oct 2024, 21:00
ROIV Roivant Sciences Ltd. 12 Sep 2024 1 -$51,449 4 Director 16 Sep 2024, 21:00
ROIV Roivant Sciences Ltd. 10 Sep 2024 2 $0 4 Director 12 Sep 2024, 21:00
ROIV Roivant Sciences Ltd. 23 Jul 2024 1 $0 4 Director 25 Jul 2024, 21:00
NAUT Nautilus Biotechnology, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 17:37
ROIV Roivant Sciences Ltd. 24 Apr 2024 2 -$1,340 4 Director 26 Apr 2024, 21:01
KNTE Kinnate Biopharma Inc. 03 Apr 2024 4 $0 4 Director 05 Apr 2024, 16:55
ZNTL Zentalis Pharmaceuticals, Inc. 12 Feb 2024 1 -$29,435 4 Chief Financial Officer 12 Feb 2024, 20:22
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2024 3 -$100,040 4 Chief Financial Officer 05 Feb 2024, 19:12
ROIV Roivant Sciences Ltd. 19 Jan 2024 1 $0 4 Director 23 Jan 2024, 21:00
ROIV Roivant Sciences Ltd. 16 Oct 2023 1 $0 4 Director 18 Oct 2023, 21:30
ZNTL Zentalis Pharmaceuticals, Inc. 04 Oct 2023 2 -$106,925 4 Chief Financial Officer 06 Oct 2023, 19:18
ROIV Roivant Sciences Ltd. 12 Sep 2023 2 $0 4 Director 14 Sep 2023, 22:31
ROIV Roivant Sciences Ltd. 03 Jul 2023 1 $0 4 Director 06 Jul 2023, 21:30
NAUT Nautilus Biotechnology, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 19:52
KNTE Kinnate Biopharma Inc. 12 Jun 2023 1 $0 4 Director 13 Jun 2023, 18:26
ZNTL Zentalis Pharmaceuticals, Inc. 13 Feb 2023 2 -$158,004 4 Chief Financial Officer 14 Feb 2023, 18:10
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2023 2 $0 4 Chief Financial Officer 01 Feb 2023, 18:07
ZNTL Zentalis Pharmaceuticals, Inc. 03 Oct 2022 1 $0 4 Chief Financial Officer 03 Oct 2022, 18:42
ROIV Roivant Sciences Ltd. 20 Jul 2022 1 $0 4 Director 25 Jul 2022, 06:06
ROIV Roivant Sciences Ltd. 29 Jun 2022 0 $0 3 Director 11 Jul 2022, 17:01
NAUT Nautilus Biotechnology, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:03
KNTE Kinnate Biopharma Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 17:00
ZNTL Zentalis Pharmaceuticals, Inc. 04 Apr 2022 5 -$855,522 4 Chief Financial Officer 05 Apr 2022, 18:53
ZNTL Zentalis Pharmaceuticals, Inc. 23 Feb 2022 2 -$93,920 4 Chief Financial Officer 23 Feb 2022, 19:12
ZNTL Zentalis Pharmaceuticals, Inc. 10 Feb 2022 2 $0 4 Chief Financial Officer 14 Feb 2022, 20:09
ZNTL Zentalis Pharmaceuticals, Inc. 02 Oct 2021 1 -$1,146,580 4 Chief Financial Officer 04 Oct 2021, 21:16
ZNTL Zentalis Pharmaceuticals, Inc. 18 Aug 2021 2 $499,748 4 Chief Financial Officer 20 Aug 2021, 12:59
ZNTL Zentalis Pharmaceuticals, Inc. 01 Jul 2021 4 -$158,054 4 Chief Financial Officer 06 Jul 2021, 20:01
KNTE Kinnate Biopharma Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 19:13
NAUT Nautilus Biotechnology, Inc. 09 Jun 2021 0 $0 3 Director 09 Jun 2021, 21:41
ZNTL Zentalis Pharmaceuticals, Inc. 01 Jun 2021 2 -$166,640 4 Chief Financial Officer 02 Jun 2021, 20:26